Guyasuta Investment Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $424K | Buy |
1,644
+3
| +0.2% | +$774 | 0.03% | 172 |
|
|
2025
Q1 | $367K | Buy |
1,641
+4
| +0.2% | +$895 | 0.02% | 178 |
|
|
2024
Q4 | $374K | Buy |
1,637
+3
| +0.2% | +$686 | 0.02% | 189 |
|
|
2024
Q3 | $399K | Buy |
1,634
+10
| +0.6% | +$2.44K | 0.02% | 182 |
|
|
2024
Q2 | $279K | Hold |
1,624
| – | – | 0.02% | 193 |
|
|
2024
Q1 | $279K | Hold |
1,624
| – | – | 0.02% | 196 |
|
|
2023
Q4 | $279K | Buy |
1,624
+4
| +0.2% | +$688 | 0.02% | 196 |
|
|
2023
Q3 | $240K | Buy |
1,620
+6
| +0.4% | +$887 | 0.02% | 212 |
|
|
2023
Q2 | $353K | Buy |
1,614
+3
| +0.2% | +$656 | 0.03% | 180 |
|
|
2023
Q1 | $353K | Buy |
1,611
+3
| +0.2% | +$657 | 0.03% | 182 |
|
|
2022
Q4 | $335K | Buy |
1,608
+3
| +0.2% | +$624 | 0.03% | 178 |
|
|
2022
Q3 | $350K | Buy |
1,605
+3
| +0.2% | +$654 | 0.03% | 164 |
|
|
2022
Q2 | $336K | Buy |
1,602
+86
| +6% | +$18K | 0.03% | 201 |
|
|
2022
Q1 | $368K | Buy |
1,516
+3
| +0.2% | +$728 | 0.03% | 210 |
|
|
2021
Q4 | $394K | Buy |
1,513
+2
| +0.1% | +$521 | 0.03% | 212 |
|
|
2021
Q3 | $398K | Buy |
1,511
+3
| +0.2% | +$790 | 0.03% | 201 |
|
|
2021
Q2 | $372K | Buy |
1,508
+2
| +0.1% | +$493 | 0.03% | 204 |
|
|
2021
Q1 | $292K | Buy |
1,506
+3
| +0.2% | +$582 | 0.02% | 209 |
|
|
2020
Q4 | $319K | Buy |
1,503
+3
| +0.2% | +$637 | 0.03% | 191 |
|
|
2020
Q3 | $257K | Hold |
1,500
| – | – | 0.02% | 194 |
|
|
2020
Q2 | $288K | Hold |
1,500
| – | – | 0.03% | 178 |
|
|
2020
Q1 | $221K | Hold |
1,500
| – | – | 0.03% | 175 |
|
|
2019
Q4 | $232K | Hold |
1,500
| – | – | 0.02% | 197 |
|
|
2019
Q3 | $203K | Buy |
+1,500
| New | +$203K | 0.02% | 200 |
|